Results 41 to 50 of about 14,372 (211)

Selective and rapid determination of raltegravir in human plasma by liquid chromatography–tandem mass spectrometry in the negative ionization mode

open access: yesJournal of Pharmaceutical Analysis, 2015
A selective and rapid high-performance liquid chromatography–tandem mass spectrometry method was developed and validated for the quantification of raltegravir using raltegravir-d3 as an internal standard (IS).
Ajay Gupta   +5 more
doaj   +1 more source

First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens

open access: yesAntimicrobial Resistance and Infection Control, 2020
Sub-Saharan African countries are transitioning to dolutegravir-based regimens, even for patients with extensive previous drug exposure, including first-generation integrase strand-transfer inhibitors (INSTI) such as raltegravir. Such exposure might have
J. Fokam   +23 more
semanticscholar   +1 more source

Restoring Meropenem Activity Against VIM-1-Producing Klebsiella pneumoniae Through Zinc-Binding Ligands. [PDF]

open access: yesChembiochem
Approved zinc‐binding drugs and newly synthesized HisPyr ligands were evaluated as adjuvants to meropenem against metallo‐β‐lactamase‐producing Klebsiella pneumoniae. Chlorpropamide and D‐penicillamine restored meropenem activity against the VIM‐1‐producing strain, while computational analyses supported interactions with the enzyme's binuclear zinc ...
Ragusa C   +6 more
europepmc   +2 more sources

Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI.

open access: yesPLoS ONE, 2016
BackgroundIrinotecan toxicity correlates with UGT1A1 activity. We explored whether phenotyping UGT1A1 using a probe approach works better than current genotyping methods.MethodsTwenty-four Asian cancer patients received irinotecan as part of the FOLFIRI ...
Lawrence Soon-U Lee   +13 more
doaj   +1 more source

Raltegravir Versus Efavirenz in Antiretroviral-Naive Pregnant Women Living With HIV (NICHD P1081): An Open-Label, Randomised, Controlled, Phase 4 Trial

open access: yesThe Lancet HIV, 2020
Summary Background While antiretroviral regimens containing integrase inhibitors rapidly suppress HIV viral load in non-pregnant adults, few published randomized trial data have compared the safety and efficacy of any integrase inhibitor to efavirenz ...
E. João   +27 more
semanticscholar   +1 more source

Raltegravir: penghambat enzim integrase HIV-1 [PDF]

open access: yes, 2014
Raltegravir efektif digunakan sebagai bagian dari kombinasi ART baik untuk pasien treatment-naive maupun pasien treatmentexperienced; aturan pemberian raltegravir dua kali per hari (BID). Harga raltegravir lebih mahal daripada harga jenis ART lain.
Herawati, Fauna
core   +2 more sources

A phase IV, open-label three-arm study investigating the impact of a combination of tenofovir disoproxil fumarate/emtricitabine with raltegravir or dolutegravir or elvitegravir/cobicistat on renal function in HIV-1 antiretroviral naïve patients

open access: yesHIV Research & Clinical Practice, 2021
Objectives: Tenofovir DF (TDF) remains one of the preferred backbone agents for naïve HIV patients starting antiretroviral treatment (ART). The impact of TDF on renal function and metabolic parameters may vary by anchor agent.
Margherita Bracchi   +8 more
doaj   +1 more source

Direct Regioselective para‐Fluorination via I(I)/I(III) Catalysis

open access: yesAngewandte Chemie, Volume 138, Issue 37, 7 September 2026.
A direct, para‐selective fluorination by I(I)/I(III) catalysis is disclosed that does not require substrate pre‐functionalization. This strategy leverages the Leonard link inherent to phenylpropanoate and phenylpropanamides to promote a spirocyclization/para‐selective sequence. The C3‐side chain maps onto a range of common drug scaffolds and allows the
Christoph Roblick   +5 more
wiley   +2 more sources

Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
IntroductionSecond-generation integrase strand transfer inhibitors (INSTIs) are preferred treatment options worldwide, and dolutegravir (DTG) is the treatment of choice in resource-limited settings.
José Ramón Santos   +64 more
doaj   +1 more source

HIV resistance to raltegravir [PDF]

open access: yes, 2009
Similar to all antiretroviral drugs, failure of raltegravirbased treatment regimens to fully supress HIV replication almost invariably results in emergence of HIV resistance to this new drug.
Clavel, François, Clavel François
core   +2 more sources

Home - About - Disclaimer - Privacy